CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR–Cas9 nuclease off-targets
Shengdar Q. Tsai(Harvard University), J. Keith Joung(Massachusetts General Hospital), Ved V. Topkar(Massachusetts General Hospital), Martin J. Aryee(Johns Hopkins University), Jose Malagon-Lopez(GeneFluidics (United States)), Nathalie T. Nguyen(Massachusetts General Hospital)
Cited by 831
Related Papers
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
|Nature Biotechnology|2013|3.3k
CRISPR-Cas systems for editing, regulating and targeting genomes
|Nature Biotechnology|2014|3.2k
Efficient genome editing in zebrafish using a CRISPR-Cas system
|Nature Biotechnology|2013|3k
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
|Nature|2016|2.7k
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
|Nature Biotechnology|2014|2.3k